Bloomberg Markets: Abercrombie & Fitch Plunges, Coke Endowments

Bloomberg Markets: Abercrombie & Fitch Plunge...

Up next

Admin's Mixed Messages on Iran Stoke More Volatility

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Energy markets whipsawed for a second consecutive day as investors raced to interpret rapidly shifting comments from the Trump administration over th ...  Show more

Calvin Klein Is Missing Its Carolyn Bessette Kennedy Moment

As fans of FX’s new limited series, Love Story: John F. Kennedy Jr. & Carolyn Bessette search for real-life versions of the characters' wardrobes, they're running into roadblocks. According to Google Trends, searches for “Calvin Klein 90s” shot up 850% in the US the week Love Sto ...  Show more

Recommended Episodes

Michael Bloomberg's Dark And Terrible Life Story
Worst Year Ever

Robert, Katy, and Cody discuss former New York Mayor and presidential candidate, Michael Bloomberg. Best Bloomberg Ever! Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/listener for privacy information. 

BONUS EPISODE: Bloomberg Surveillance in Jackson Hole
Odd Lots

Bloomberg Surveillance comes to the Odd Lots podcast!  Listen for a special edition of Bloomberg Surveillance from the Federal Reserve's annual symposium in Jackson Hole, Wyoming.  Hear more from Bloomberg Surveillance on Apple or Spotify. Guests in this episode: Mohamed El-Erian ...  Show more

Bloomberg Wall Street Week: May 27th, 2022
Wall Street Week

One of the most iconic brands in financial television returns for today's issues and today's world. On this edition of Wall Street Week, Liz Ann Sonders, Charles Schwab Chief Investment Strategist & Ben Inker, GMO Co-Head of Asset Allocation wrap up a volatile week in the markets ...  Show more

Bloomberg Surveillance: Bloomberg BNA's Eleanor Tyler on pharma
Bloomberg Surveillance

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more